Platinum Partners
Business Wire Science
NASA Selects Orbital for Major Sounding Rocket Program Prime Contract
DULLES, Va.--(BUSINESS WIRE)--Orbital Sciences Corporation (NYSE:ORB), one of the world’s leading space technology companies, today announced that it was selected by the National Aeronautics and Space Administration (NASA) for the prime contractor role on the NASA Sounding Rocket Operations Contract II (NSROC II) program. The indefinite delivery/indefinite quantity NSROC II contract carries a maximum total value of $310 million over its five-year term, with a current expected value of at least $
Fri, 30 Jul 2010 13:44:00 UT
Rosetta Genomics to Present at Leerink Swan’s Life Science Tools and Diagnostics Roundtable Conference
PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG) a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be participating in a panel discussion entitled, “Issues and Opportunities in Molecular Diagnostics,” at 11:00 a.m. and will be presenting a corporate update at 1:10 p.m. at Leerink Swan’s Life Science Tools and Diagnostics Roundtable Conference being held on Thursday, Augus
Fri, 30 Jul 2010 12:00:00 UT
Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron’s Investigational New Drug (IND) application has been lifted and the company’s Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed. The FDA notification enables Geron to move forward with the world’s first clinical trial of a human embryonic stem cell (hESC)-based t
Fri, 30 Jul 2010 11:30:00 UT
Russian Cosmonaut Supports Animal Defenders International Opposition to NASA Primate Experimentation for Space Research
LOS ANGELES--(BUSINESS WIRE)--Celebrated Russian Cosmonaut Valentin Lebedev Supports Animal Defenders International Opposition to NASA Primate Experimentation for Space Research
Fri, 30 Jul 2010 10:00:00 UT
ESI stellt VA One 2010 vor
PARIS--(BUSINESS WIRE)--ESI Group: ISIN FR0004110310 VA One ist eine Komplettlösung zur “Noise and Vibration”-Simulation (Geräusche und Vibrationen) über den gesamten Frequenzbereich. In einem einzigen Simulationsmodell werden dabei Finite Elemente, Boundary Elemente und die ‘Statistical Energy Analysis’ (SEA) nahtlos miteinander kombiniert. Die neue Version enthält über 80 wichtige Verbesserungen und hat ihren Schwerpunkt auf verbesserten Methoden zur Response-Diagnose. Modernste Methoden zur R
Fri, 30 Jul 2010 08:08:00 UT
日立全新操作环境HT7700型透射电子显微镜
东京--(BUSINESS WIRE)--株式会社日立高新技术（执行董事社长：大林 秀仁／以下称日立高新技术）此次将繁杂的操作统一于显示器画面上，开发出能够在明亮的室内进行观察的新型透射电子显微镜(TEM)(*) “HT7700”，该产品将于2010年8月起面向海外市场销售。 此次日立高新技术销售的“HT7700”是日立TEM H-7000系列的最新机型, 该系列已在全世界销售超过800台。这是一款划时代的新产品，为使其在同系列的主要用途——生物制药到纳米技术和软材料等广泛的领域中得到应用，日立高新技术赋予它优异的操作性与多样的数码图像功能。通过将照相机与显微镜主机的操作相统一，既可以在显示器画面上简单地进行操作，又能在通常明亮的室内进行观察。 本产品计划在2010年8月1日美国俄勒冈州波特兰举办的“M&M2010”(Microscopy & Microanalysis 2010)上进行实机展示。 【“HT7700”的主要特点】 1. 将TEM操作统一于显示器上，无需直视荧光板，实现了无胶片化，可以在明亮的室内进行观察。另外，以往在荧光板上发暗而难于识别的图像在
Fri, 30 Jul 2010 01:00:00 UT
SRI Consulting Identifies Opportunities in Surfactants
MENLO PARK, Calif.--(BUSINESS WIRE)--The highest growth rates in consumption for surfactants are expected in Latin America, China, Middle East and Africa. The world’s supply/demand patterns are changing as major surfactants producers continue to expand their operations to Southeast Asia, China, Latin America, and Central and Eastern Europe. Overall, surfactant manufacturers, even those in Asia, continue to see their margins eroded by increasing feedstock and energy costs and hurdles in building
Thu, 29 Jul 2010 22:22:00 UT
Inhibitex to Host Conference Call to Report Second Quarter Financial Results on August 10, 2010
ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a conference call on Tuesday, August 10, 2010 at 9:00 a.m. EDT to review the Company’s second quarter financial results and provide an update on recent corporate developments. The Company will issue a press release regarding its financial results on the same day, prior to the conference call. Webcast Information To access the conference call, please dial (877) 407-9210 (domestic) or (201) 689-8049 (interna
Thu, 29 Jul 2010 21:09:00 UT
X PRIZE Foundation Announces Wendy Schmidt Oil Cleanup X CHALLENGE
WASHINGTON--(BUSINESS WIRE)--$1.4 Million X CHALLENGE for Demonstration of Rapidly Deployable, Highly Efficient Methods for Cleaning Up Crude Oil on the Ocean Surface
Thu, 29 Jul 2010 20:40:00 UT
Helicos Announces Nature Publication on First Evidence of RNA Copying Mechanisms in Human Cells
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS) today announced a publication demonstrating the detection and quantification of novel small RNA molecules using Helicos’ single-molecule sequencing technology. These data confirm a long-held, unproven hypothesis that mammalian cells are capable of synthesizing RNA by copying RNA molecules directly. The findings are presented in a paper, entitled “New class of gene-termini-associated human RNAs suggests a novel RNA
Thu, 29 Jul 2010 20:30:00 UT
Response Genetics, Inc. to Announce Second Quarter 2010 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its financial results for this period in a press release to be issued before the market opens on Thursday, August 5, 2010. About Response Genetics, Inc. Response Genetics Inc. (“RGI”) is focused on the development and sale of molecular diagnostic tests for cancer. RGI’s technologies enable extraction and analysis o
Thu, 29 Jul 2010 20:30:00 UT
NPS Pharmaceuticals to Present at Upcoming Conferences
BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York on Thursday, August 5, 2010 at 2:15 p.m. ET and the Canaccord Genuity 30th Annual Growth Conference in Boston on Tuesday, August 10, 2010 at 2:30 p.m. ET. Presentations will be available as live webcasts with replays available approxima
Thu, 29 Jul 2010 20:10:00 UT
On Assignment Reports Second Quarter 2010 Results
CALABASAS, Calif.--(BUSINESS WIRE)--On Assignment, Inc. (NASDAQ: ASGN), a diversified professional staffing firm providing flexible and permanent staffing solutions in specialty skills including Laboratory/Scientific, Healthcare/Nursing, Physicians, Medical Financial, Information Technology and Engineering, today reported results for the quarter ended June 30, 2010. Second Quarter 2010 Highlights: Consolidated Revenues grew 2.6% over Q209 and 8.5% over the first quarter of 2010. Consolidated Gro
Thu, 29 Jul 2010 20:01:00 UT
National Wind Coordinating Collaborative Sage-Grouse Research Collaborative Releases Request for Proposals
WASHINGTON--(BUSINESS WIRE)--RFP released to examine the impacts of wind power development on greater sage-grouse across the species’ range.
Thu, 29 Jul 2010 19:54:00 UT
The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief Operating Officer
NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced the appointment of Walter Capone to Chief Operating Officer. Capone will serve on the Executive Committee for the MMRF, a leading cancer research organization, and will report directly to Kathy Giusti, MMRF Founder and Chief Executive Officer. “Walter’s extensive experience in overseeing drug development and commercialization will enable the MMRF to vigorously move forward on our quest to develop nex
Thu, 29 Jul 2010 19:38:00 UT
Bio-Path Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its Liposomal Grb-2 Cancer Drug Candidate
HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCBB: BPTH) (“Bio-Path”), a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS). Bio-Path is developing a neutral lipid-based li
Thu, 29 Jul 2010 18:11:00 UT
Sion Power’s Lithium-Sulfur Batteries Power World Record Flight
TUCSON, Ariz.--(BUSINESS WIRE)--Sion Power announced today that their proprietary lithium sulfur (Li-S) batteries played a critical role in the QinetiQ Zephyr smashing the world record for the longest duration unmanned flight. A result of an intensive joint development effort between Sion Power and QinetiQ, the Zephyr flight exceeded 336 hours (14 days) of continuous flight, significantly surpassing the previous official record of 30 hours 24 minutes set by Northrop Grumman's RQ-4A Global Hawk i
Thu, 29 Jul 2010 17:45:00 UT
Research and Markets: Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling - Essential for Everyone Working in Psychiatric Research
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7d528a/systems_biology_in) has announced the addition of John Wiley and Sons Ltd's new book "Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling" to their offering. This first book to provide a comprehensive overview of the recent progress made in this break-through approach includes expert contributions from a variety of disciplines. Particular focus is placed on hig
Thu, 29 Jul 2010 17:00:00 UT
Research and Markets: Time Matters: Geology's Legacy to Scientific Thought
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/770d61/time_matters_geol) has announced the addition of John Wiley and Sons Ltd's new book "Time Matters: Geology's Legacy to Scientific Thought" to their offering. Time Matters provides an invaluable insight into the background behind some of the key concepts we use in Earth science today. It shows the historical context in which these ideas were developed, the important contributions of individual scienti
Thu, 29 Jul 2010 16:40:00 UT
Hitachi High-Tech Develops HT7700 - a New Class of Transmission Electron Microscope Enabling Novel Work Environments
TOKYO--(BUSINESS WIRE)--Hitachi High-Technologies Corporation has announced the development and release of the HT7700, a new type of transmission electron microscope (TEM)
Thu, 29 Jul 2010 16:00:00 UT
Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular Diagnostic Applications at AACC Annual Meeting
ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix CARD™ Technology Fully Automated Analytic Platform Demonstrates Accuracy and Versatility in Viral Detection, Pathogen Identification and SNP Analysis in Three Posters at AACC
Thu, 29 Jul 2010 16:00:00 UT
RPSEA Releases 2010 Small Producer Program RFPs
SUGAR LAND, Texas--(BUSINESS WIRE)--$3.2 Million to Fund Small Producer R&D Projects to Secure Energy for America
Thu, 29 Jul 2010 15:44:00 UT
Research and Markets: Data Analysis in Forensic Science: A Bayesian Decision Perspective Explores the Bayesian Decision-Theoretic Perspective Further
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f6c366/data_analysis_in_f) has announced the addition of John Wiley and Sons Ltd's new book "Data Analysis in Forensic Science: A Bayesian Decision Perspective" to their offering. This is the first text to examine the use of statistical methods in forensic science and bayesian statistics in combination. The book is split into two parts: Part One concentrates on the philosophies of statistical inference. Cha
Thu, 29 Jul 2010 15:02:00 UT
Samenvatting: ESI lanceert VA One 2010
PARIS--(BUSINESS WIRE)--ESI (ESI Group: ISIN FR0004110310) lanceert een nieuwe editie van zijn geluids- en vibratiesimulatiesoftware met geavanceerde methodes voor responsdiagnose. VA One is een complete oplossing voor geluids- en vibratiesimulatie via het volledige frequentiespectrum en combineert Finite Elements, Boundary Elements en Statistical Energy Analysis (SEA) in een enkel model. Deze nieuwe editie is voorzien van 80 nieuwe functies en gericht op nog accuratere responsdiagnose. Het diag
Thu, 29 Jul 2010 14:59:00 UT
Study Analysis Identifies Potential Biomarkers of VELCADE (Bortezomib) Activity in Patients with Relapsed Mantle Cell Lymphoma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium reports new correlative science data from the pivotal PINNACLE trial in patients with relapsed/refractory MCL, highlighting the potential usefulness of biomarkers in predicting outcomes.
Thu, 29 Jul 2010 14:19:00 UT